Table 3 Demographic distribution of cases and controls according to their genotypes and homocysteine, vitamin B12 and folic acid levels
Cases (CC) (n = 19) | Cases (CT or TT) (n = 22) | Controls (CC) (n = 21) | Controls (CT or TT) (n = 22) | *P-value | |
|---|---|---|---|---|---|
Males, n (%) | 11 (42.10) | 11 (50.00) | 10 (47.60) | 11 (50.00) | |
Chinese | 3 (27.27) | 3 (27.27) | 2 (20.00) | 2 (18.18) | |
Indian | 2 (18.18) | 2 (18.18) | 2 (20.00) | 4 (36.36) | |
Malay | 6 (54.55) | 6 (54.55) | 6 (60.00) | 5 (45.45) | |
Females, n (%) | 8 (42.10) | 11 (50.00) | 11 (52.38) | 11 (50.00) | |
Chinese | 2 (25.00) | 3 (27.27) | 3 (27.27) | 4 (36.36) | |
Indian | 3 (37.50) | 5 (45.45) | 5 (45.45) | 4 (36.36) | |
Malay | 3 (37.50) | 3 (27.27) | 3 (27.27) | 3 (27.27) | |
Age, mean ± SD | 38.41 ± 12.36 | 45.91 ± 13.17 | 43.43 ± 11.93 | 43.64 ± 10.84 | |
PASI score, mean ± SD | 9.22 ± 10.85 | 6.37 ± 4.97 | N/A | N/A | |
Homocysteine (μmol/L) | 14.92 ± 4.13 | 16.31 ± 4.56 | 15.42 ± 3.81 | 14.39 ± 3.59 | [p = 0.440] |
Vitamin B12 (pg/mL) | 482.22 ± 156.98 | 465.84 ± 210.73 | 396.38 ± 96.06 | 444.20 ± 112.19 | [p = 0.270] |
Folic acid (ng/mL) | 7.66 ± 3.91 | 7.24 ± 4.61 | 6.62 ± 3.19 | 9.14 ± 6.40 | [p = 0.270] |